Effects of basic carbohydrate counting versus standard outpatient nutritional education (The BCC Study): study protocol for a randomised, parallel open-label, intervention study fo...

por Ewers, Bettina, Bruun, Jens Meldgaard, Vilsbøll, Tina
Publicado 2019

A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes

por Andersen, Andreas, Knop, Filip Krag, Vilsbøll, Tina
Publicado 2021

Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes – a review

por Hansen, Katrine B, Vilsbøll, Tina, Knop, Filip K
Publicado 2010

Effects of lixisenatide on elevated liver transaminases: systematic review with individual patient data meta-analysis of randomised controlled trials on patients with type 2 diabet...

por Gluud, Lise L, Knop, Filip K, Vilsbøll, Tina
Publicado 2014

Effects of glucagon‐like peptide‐1 receptor agonists on cardiovascular risk factors: A narrative review of head‐to‐head comparisons

por Dalsgaard, Niels B., Vilsbøll, Tina, Knop, Filip K.
Publicado 2017

Transitioning from basal–bolus or premix insulin therapy to a combination of basal insulin and glucagon‐like peptide‐1 receptor agonist in people with type 2 diabetes

por Mehta, Roopa, Billings, Liana K., Liebl, Andreas, Vilsbøll, Tina
Publicado 2022

Type 2 Diabetes Patients Reach Target Glycemic Control Faster Using IDegLira than Either Insulin Degludec or Liraglutide Given Alone

por Vilsbøll, Tina, Vora, Jiten, Jarlov, Henrik, Kvist, Kajsa, Blonde, Lawrence
Publicado 2016

The dietary education trial in carbohydrate counting (DIET-CARB Study): study protocol for a randomised, parallel, open-label, intervention study comparing different approaches to...

por Ewers, Bettina, Vilsbøll, Tina, Andersen, Henrik Ullits, Bruun, Jens Meldgaard
Publicado 2019

Hypoglycaemia and cardiac arrhythmias in diabetes

por Andersen, Andreas, Jørgensen, Peter G., Knop, Filip K., Vilsbøll, Tina
Publicado 2020

How glucagon-like peptide 1 receptor agonists work

por Andreasen, Christine Rode, Andersen, Andreas, Knop, Filip Krag, Vilsbøll, Tina
Publicado 2021

Incretin-Based Therapies: Viewpoints on the way to consensus

por Nauck, Michael. A., Vilsbøll, Tina, Gallwitz, Baptist, Garber, Alan, Madsbad, Sten
Publicado 2009

The quality of dietary carbohydrate and fat is associated with better metabolic control in persons with type 1 and type 2 diabetes

por Jacobsen, Sabine S., Vistisen, Dorte, Vilsbøll, Tina, Bruun, Jens M., Ewers, Bettina
Publicado 2020

Glucose-Dependent Insulinotropic Polypeptide: A Bifunctional Glucose-Dependent Regulator of Glucagon and Insulin Secretion in Humans

por Christensen, Mikkel, Vedtofte, Louise, Holst, Jens J., Vilsbøll, Tina, Knop, Filip K.
Publicado 2011

Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes

por Holst, Jens J., Knop, Filip K., Vilsbøll, Tina, Krarup, Thure, Madsbad, Sten
Publicado 2011

Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: protocol for systematic review and meta-analysis of clinical studies

por Rohde, Ulrich, Hedbäck, Nora, Gluud, Lise L, Vilsbøll, Tina, Knop, Filip K
Publicado 2013

The effects of sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes: protocol for a systematic review with meta-analysis of randomised trials

por Storgaard, Heidi, Gluud, Lise Lotte, Christensen, Mikkel, Knop, Filip Krag, Vilsbøll, Tina
Publicado 2014

Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat

por Mathiesen, David S., Lund, Asger, Vilsbøll, Tina, Knop, Filip K., Bagger, Jonatan I.
Publicado 2021

Intention and Perceptions of Healthy Eating versus Actual Intake Among Patients with Type 1 and Type 2 Diabetes and the General Population

por Ewers, Bettina, Sørensen, Mette Rosenlund, Fagt, Sisse, Diaz, Lars J, Vilsbøll, Tina
Publicado 2021

Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials

por Vilsbøll, Tina, Christensen, Mikkel, Junker, Anders E, Knop, Filip K, Gluud, Lise Lotte
Publicado 2012

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD

por Seghieri, Marta, Christensen, Alexander S., Andersen, Andreas, Solini, Anna, Knop, Filip K., Vilsbøll, Tina
Publicado 2018